Streetbeat News

RDUS

Radius Health, Inc.

Industry

Drug Manufacturers - Specialty & Generic

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

U.S. equities remained stable as Fed Chair Jerome Powell reassured on disinflation progress and warned about national debt risks. Tesla surged over 9% on better-than-expected Q2 deliveries. Job openings spiked, and major indices showed minimal movement. Key ETFs and stocks had mixed performances.

Portfolio Pulse from Piero Cingari

July 02, 2024 | 5:41 pm

Radius Recycling, Inc. (NASDAQ:RDUS) shares fell 13.2% after the company reported worse-than-expected Q3 sales results. Revenue missed estimates, and key metrics like ferrous sales volumes, average net ferrous sales prices, and gross margin declined significantly. Despite these challenges, the company highlighted benefits from its cost reduction and productivity improvement plan.

Portfolio Pulse from Lekha Gupta

July 02, 2024 | 3:44 pm

Radius Recycling shares are trading lower after the company reported worse-than-expected Q3 sales results.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 1:51 pm

Schnitzer Steel (NASDAQ:RDUS) reported Q3 2024 adjusted EPS of $(0.59), beating the estimate of $(0.66). However, sales of $673.920 million missed the $693.900 million estimate, marking a 16.76% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 12:03 pm

U.S. stock futures are trading lower this morning. Key stocks to watch include MSC Industrial Direct (MSM), Y-mAbs Therapeutics (YMAB), Radius Recycling (RDUS), Fly-E Group (FLYE), and Simulations Plus (SLP). MSC Industrial Direct is expected to report earnings of $1.50 per share on $1.01 million revenue. Y-mAbs Therapeutics appointed a new CFO. Radius Recycling is expected to post a quarterly loss. Fly-E Group reported increased earnings and revenue. Simulations Plus is expected to post earnings of $0.15 per share on $17.96 million revenue.

Portfolio Pulse from Avi Kapoor

July 02, 2024 | 6:29 am

Seaport Global analyst Martin Englert has upgraded Radius Recycling (NASDAQ:RDUS) from Sell to Neutral.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 2:44 pm

Radius Recycling reported a Q2 loss with challenges in recycled metal supplies and U.S. manufacturing. American Battery received a $40.5 million award for a new recycling facility. Nexa Resources priced a $600 million offering. Newmont saw mixed investor sentiment. Vale S.A. had its price target lowered by Deutsche Bank.

Portfolio Pulse from Austin DeNoce

April 04, 2024 | 9:01 pm

Radius Recycling, Inc. (NASDAQ:RDUS) shares dropped after reporting Q2 2024 results with revenue of $621.06 million, slightly below consensus. Gross margin and adjusted EBITDA significantly declined from the previous year, with ferrous sales volumes and adjusted EBITDA per ferrous ton sold also decreasing. However, average net ferrous sales prices increased, and finished steel sales volumes rose due to strong demand in the Western U.S. The company announced a plan to cut costs and declared a dividend of $0.1875 per share. Exposure to RDUS can also be gained through ETFs EVX and XME.

Portfolio Pulse from Lekha Gupta

April 04, 2024 | 4:25 pm

Schnitzer Steel reported Q2 adjusted losses of $(1.04) per share, surpassing the $(1.09) estimate, but its sales of $621.06M fell short of the $626.15M estimate. This represents a significant decrease in performance compared to the same period last year, with earnings down 842.86% and sales down 17.84%.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 12:08 pm

Earnings reports for April 4, 2024, include a mix of expected profits and losses across various sectors. Notable companies like Conagra Brands, Trinity Biotech, and AngioDynamics are set to report before the bell, with projections ranging from profits to losses. WisdomTree International LargeCap Dividend Fund and others also anticipate earnings, while companies like Conifer Holdings and Movano will report after the bell.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 9:18 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.